13 Results for "

XDR

" in MedChemExpress (MCE) Product Catalog:
Products (13)

13 Results for "XDR" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-W016420
CAS No.: 26016-99-9
Synonyms: MK-0955 sodium
Fosfomycin (MK-0955) sodium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin sodium shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria .
loading...
    loading...
15
15 Publications Verification
Cat. No.: HY-B1075
CAS No.: 26016-98-8
Synonyms: MK-​0955 calcium
Target:  

Bacterial Antibiotic

Research Areas:  

Infection Cancer

Fosfomycin (MK-0955) calcium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin calcium shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria .
loading...
    loading...
15
15 Publications Verification
Cat. No.: HY-B0609
CAS No.: 78964-85-9
Synonyms: MK-0955 tromethamine
Target:  

Bacterial Antibiotic

Research Areas:  

Infection Cancer

Fosfomycin (MK-0955) tromethamine is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin tromethamine shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria .
loading...
    loading...
Cat. No.: HY-B1075A
CAS No.: 23155-02-4
Synonyms: MK-0955
Target:  

Bacterial Antibiotic

Research Areas:  

Infection Cancer

Fosfomycin (MK-0955) is a broad-spectrum antibiotic. Fosfomycin can cross blood-brain barrier penetrating, and irreversibly inhibits an early stage in cell wall synthesis. Fosfomycin shows anti-bacteria activity for a range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria .
loading...
    loading...
Cat. No.: HY-W016420R
CAS No.: 26016-99-9
Synonyms: MK-0955 sodium (Standard)
Pulchinenoside C (Standard) is the analytical standard of Pulchinenoside C. This product is intended for research and analytical applications. Pulchinenoside C (Anemoside B4) is a natural compound of the herbaceous peony saponin B4, which has many biological effects, such as antitumor, neuroprotective, and anti-angiogenic activities.
loading...
    loading...
Cat. No.: HY-P5704
CAS No.: 1398109-79-9
Target:  

Bacterial

Research Areas:  

Infection

K11 is an antimicrobial peptide. K11 is active against MDR/XDR K. pneumoniae isolates (MIC: 8-512 μg/mL), and inhibits bacterial biofilm formation. K11 can act synergistically with antibiotics (Chloramphenicol (HY-B0239), Meropenem (HY-13678), Rifampicin (HY-B0272), etc.) against drug-resistant K. pneumoniae. K11 has high thermal and wide pH stability .
loading...
    loading...
Cat. No.: HY-B1075R
CAS No.: 26016-98-8
Synonyms: MK-​0955 calcium (Standard)
Research Areas:  

Infection Cancer

Fosfomycin (calcium) (Standard) is the analytical standard of Fosfomycin (calcium). This product is intended for research and analytical applications. Fosfomycin (MK-0955) calcium is a blood-brain barrier penetrating, broad-spectrum antibiotic by irreversibly inhibiting an early stage in cell wall synthesis. Fosfomycin calcium shows both in vivo and in vitro activity against a wide range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria .
loading...
    loading...
Cat. No.: HY-B1075AS
CAS No.: 1216461-18-5
Synonyms: MK-0955 (benzylamine)-13C3
(Rac)-Fosfomycin (benzylamine)- 13C3 is the 13C labeled Fosfomycin . Fosfomycin (MK-0955) is a broad-spectrum antibiotic. Fosfomycin can cross blood-brain barrier penetrating, and irreversibly inhibits an early stage in cell wall synthesis. Fosfomycin shows anti-bacteria activity for a range of bacteria, including multidrug-resistant (MDR), extensively drug-resistant (XDR), and pan-drug-resistant (PDR) bacteria .
loading...
    loading...
Cat. No.: HY-149581
CAS No.: 2906099-98-5
Target:  

Bacterial

Research Areas:  

Infection

DprE1-IN-9 (compound B18) is an effective reversible DprE1 inhibitor and can bind to the receptor cavity of DprE1. DprE1-IN-9 shows strong antimycobacterial activity not only against non-pathogenic strain H37Ra (MIC=0.18 µg/mL) but also against pathogenic H37Rv and the clinical MDR and XDR isolates .
loading...
    loading...
Cat. No.: HY-168123
CAS No.: 2956713-87-2
Target:  

Bacterial

Research Areas:  

Cancer

Antitubercular agent-47 (compund 5C) shows potent activity against tuberculosis and was effective against DS/MDR/XDR clinical isolates .
loading...
    loading...
Cat. No.: HY-N8388
CAS No.: 34465-83-3
Collinin is a anti-tubercular agent, it can be isolated from leaves of Z. schinifolium. Collinin has an excellent anti-tuberculosis effect against multidrug-resistant (MDR), extensively drug-resistant (XDR) strains .
loading...
    loading...
Cat. No.: HY-170970
Target:  

Bacterial

Research Areas:  

Infection

Mtb-IN-10 (Compound P15) is a Rv1625c/Cya activator that regulates cAMP metabolism to influence the growth of Mycobacterium tuberculosis (Mtb). Mtb-IN-10 exhibits an EC50 of 1.96 µM in an Mtb-infected macrophage model and demonstrates 58.0% oral bioavailability in mice at a 20 mg/kg dose. It may regulate intracellular signaling and disrupt cholesterol metabolism in Mtb, thereby inhibiting bacterial proliferation. Mtb-IN-10 holds potential for tuberculosis (TB) research, particularly for combating multidrug-resistant (MDR-TB) and extensively drug-resistant (XDR-TB) Mtb strains .
loading...
    loading...
Cat. No.: HY-179444
Target:  

Bacterial

Research Areas:  

Inflammation/Immunology

Antituberculosis agent-17 (compound 21) is a potent and selective antituberculosis agent. Antituberculosis agent-17 displays excellent anti-Tuberculosis (TB) activity against H37Rv, MDR and XDR strains of TB (MIC = 0.2-0.78 μM). Antituberculosis agent-17 exhibits selectivity for Mycobacterium tuberculosis over selected non-TB forming mycobacteria and bacteria. Antituberculosis agent-17 can be used for TB research .
loading...
    loading...
  • 1